Stock-Based Compensation for STERIS (STE)
Stock-Based Compensation for STERIS (STE): headline value $58.59M · YoY +1.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
STE
Currently viewingStock-Based CompensationSwitch metric
Latest period
$58.59M
YoY change
+1.5%
5Y CAGR
+19.2%
Peak year (2022)
$57.66M
Latest annual
$57.40M
Stock-Based Compensation history chart for STERIS (STE) from 1991 to 2025
Stock-Based Compensation history table for STERIS (STE) from 1991 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $57.40M | +1.5% | ||
| 2024 | $56.53M | +45.1% | ||
| 2023 | $38.95M | -32.4% | ||
| 2022 | $57.66M | +122.1% | ||
| 2021 | $25.97M | +9.1% | ||
| 2020 | $23.81M | -0.6% | ||
| 2019 | $23.96M | +8.0% | ||
| 2018 | $22.19M | +18.1% | ||
| 2017 | $18.79M | +16.4% | ||
| 2016 | $16.15M | +8.2% | ||
| 2015 | $14.92M | +34.4% | ||
| 2014 | $11.10M | +24.5% | ||
| 2013 | $8.92M | +13.5% | ||
| 2012 | $7.86M | -22.9% | ||
| 2011 | $10.19M | +38.2% | ||
| 2010 | $7.37M | 0.0% | ||
| 2009 | $7.37M | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — |
Stock-Based Compensation values are taken from STERIS's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of STERIS (STE) stock-based compensation is $57.40M – edged up 1.5% year-over-year.
STERIS stock-based compensation compound annual growth for the 2020–2025 (5 years) window is +19.2%, with the latest reading among the more recent periods of the dataset.
$57.66M stands as the all-time-high annual stock-based compensation, posted in 2022, against a low of $0 during 1991.
Within Healthcare, STERIS (STE) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
STERIS Stock-Based Compensation by Year
STERIS Stock-Based Compensation 2025: $57.40M
STERIS stock-based compensation in 2025 was $57.40M, edged up 1.5% from 2024.
STERIS Stock-Based Compensation 2024: $56.53M
STERIS stock-based compensation in 2024 was $56.53M, surged 45.1% from 2023.
STERIS Stock-Based Compensation 2023: $38.95M
STERIS stock-based compensation in 2023 was $38.95M, plunged 32.4% below 2022.
STERIS Stock-Based Compensation 2022: $57.66M
STERIS stock-based compensation in 2022 was $57.66M, surged 122.1% from 2021. This figure represents the highest annual value in the available history.
STERIS Stock-Based Compensation 2021: $25.97M
STERIS stock-based compensation in 2021 was $25.97M.
See more financial history for STERIS (STE).
Sector peers — Stock-Based Compensation
Companies in the same sector as STERIS, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is STERIS's stock-based compensation?
Latest reported stock-based compensation for STERIS (STE) is $58.59M (period ending December 31, 2025).
How has STERIS stock-based compensation changed year-over-year?
STERIS (STE) stock-based compensation changed +1.5% year-over-year on the latest annual filing.
What is the long-term growth rate of STERIS stock-based compensation?
STERIS (STE) stock-based compensation compound annual growth rate is +19.2% over the most recent 5 years available.
When did STERIS stock-based compensation hit its highest annual value?
STERIS stock-based compensation reached its highest annual value of $57.66M in 2022.
What was STERIS stock-based compensation in 2024?
STERIS (STE) stock-based compensation in 2024 was $56.53M.
What was STERIS stock-based compensation in 2025?
STERIS (STE) stock-based compensation in 2025 was $57.40M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
STE Overview
Company profile, financial tools, and key metrics
STE Revenue Counter
Earns $184.81 every second. See per minute, hour, and day.
STE Earnings Counter
Earns $22.44 per second net profit. See per minute, hour, and day.
STE Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
STE What If Invested
What if you had invested $1,000? See historical returns from any date.
STE How It Makes Money
Discover visual breakdown of $5.83B in revenue — where it comes from and where it goes.
STE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
STE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
STE Daily Price Character
Balanced · 49.9% historical win rate (green days). Streaks & record days.
STE Buybacks
0.83% TTM buyback yield. Shareholder yield & SBC comparison.
STE Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
STE Dividend Profile
Yield: 1.16%. Safety: 7/7. See full history.
STE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
STE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.